DaVita Inc.

NYSE:DVA 주식 보고서

시가총액: US$13.7b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

DaVita 관리

관리 기준 확인 3/4

DaVita's CEO는 Javier Rodriguez, Jun2019 에 임명되었습니다 의 임기는 5.08 년입니다. 총 연간 보상은 $ 6.71M, 21% 로 구성됩니다. 21% 급여 및 79% 보너스(회사 주식 및 옵션 포함). 는 $ 97.54M 가치에 해당하는 회사 주식의 0.8% 직접 소유합니다. 97.54M. 경영진과 이사회의 평균 재임 기간은 각각 5.5 년과 4 년입니다.

주요 정보

Javier Rodriguez

최고 경영자

US$6.7m

총 보상

CEO 급여 비율21.0%
CEO 임기5.3yrs
CEO 소유권1.0%
경영진 평균 재임 기간5.7yrs
이사회 평균 재임 기간4.1yrs

최근 관리 업데이트

Recent updates

An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

Sep 16
An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business

Sep 01
DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business

DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Jul 02
DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Jun 19
Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Jun 04
Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

May 22
Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

DaVita Stock Is A Hold As It Expands In Latin America

Mar 18

Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

Mar 13
Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Mar 04
Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 16
DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Is DaVita (NYSE:DVA) Using Too Much Debt?

Feb 08
Is DaVita (NYSE:DVA) Using Too Much Debt?

DaVita: Assessing After The Rally

Dec 29

DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity

Dec 24
DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity

DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

Nov 08
DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

DaVita: Simple And Compelling After Sell-Off

Oct 26

Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)

Oct 25
Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)

DaVita: Continued Economic Hurdles, Market Expectations May Be Correct

Oct 05

Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

Aug 14
Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt

Jul 31
DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt

DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold

Jul 21

Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down

Jul 18
Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down

DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate

Jul 03
DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate

What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?

May 01
What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?

These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively

Apr 17
These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively

Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)

Apr 03
Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)

Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?

Mar 08
Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?

DaVita HealthCare Partners Q4 2022 Earnings Preview

Feb 21

Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine

Feb 08

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Jan 24
Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Is DaVita (NYSE:DVA) A Risky Investment?

Jan 09
Is DaVita (NYSE:DVA) A Risky Investment?

DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution

Dec 12

DaVita Q3 2022 Earnings Preview

Oct 27

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Oct 18
Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

DaVita: Solid Valuation And Cash Flow, Price Recovering After SCOTUS Ruling

Sep 28

DaVita could benefit from legislation that would return dialysis protection to Medicare

Aug 16

We Think DaVita (NYSE:DVA) Is Taking Some Risk With Its Debt

Aug 14
We Think DaVita (NYSE:DVA) Is Taking Some Risk With Its Debt

CEO 보상 분석

Javier Rodriguez 의 보수는 DaVita 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

US$860m

Mar 31 2024n/an/a

US$816m

Dec 31 2023US$7mUS$1m

US$692m

Sep 30 2023n/an/a

US$596m

Jun 30 2023n/an/a

US$454m

Mar 31 2023n/an/a

US$500m

Dec 31 2022US$3mUS$1m

US$547m

Sep 30 2022n/an/a

US$680m

Jun 30 2022n/an/a

US$834m

Mar 31 2022n/an/a

US$903m

Dec 31 2021US$3mUS$1m

US$978m

Sep 30 2021n/an/a

US$984m

Jun 30 2021n/an/a

US$883m

Mar 31 2021n/an/a

US$791m

Dec 31 2020US$73mUS$1m

US$783m

Sep 30 2020n/an/a

US$832m

Jun 30 2020n/an/a

US$824m

Mar 31 2020n/an/a

US$816m

Dec 31 2019US$17mUS$1m

US$705m

Sep 30 2019n/an/a

US$623m

Jun 30 2019n/an/a

US$548m

Mar 31 2019n/an/a

US$551m

Dec 31 2018US$8mUS$900k

US$616m

Sep 30 2018n/an/a

US$617m

Jun 30 2018n/an/a

US$698m

Mar 31 2018n/an/a

US$652m

Dec 31 2017US$8mUS$900k

US$909m

보상 대 시장: Javier 의 총 보상 ($USD 6.71M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 13.50M ).

보상과 수익: Javier 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Javier Rodriguez (53 yo)

5.3yrs

테뉴어

US$6,712,328

보상

Mr. Javier J. Rodriguez serves as an Independent Director at Gilead Sciences, Inc. since June 15, 2020. He has been Chief Executive Officer and Executive Director of DaVita Inc. since June 1, 2019. Mr. Rod...

리더십 팀

이름위치테뉴어보상소유권
Javier Rodriguez
CEO & Executive Director5.3yrsUS$6.71m1.0%
$ 136.6m
Joel Ackerman
CFO & Treasurer7.6yrsUS$6.87m0.11%
$ 15.1m
Kathleen Waters
Chief Legal & Public Affairs Officer8.3yrsUS$5.61m0.069%
$ 9.5m
James Hearty
Chief Compliance Officer6.5yrsUS$2.73m0.014%
$ 2.0m
Michael Staffieri
Chief Operating Officer Emeritus10.5yrsUS$10.42m0.19%
$ 26.0m
David Maughan
Chief Operating Officerno data데이터 없음0.0072%
$ 981.0k
Christopher Berry
Group VP & Chief Accounting Officer1.1yrs데이터 없음데이터 없음
Madhu Narasimhan
Chief Information Officerless than a year데이터 없음데이터 없음
Nic Eliason
Group Vice President of Investor Relationsno data데이터 없음데이터 없음
Misha Palecek
Chief Transformation Officer of U.S. Kidney Care Businessno data데이터 없음데이터 없음
Jeffrey Giullian
Chief Medical Officer of Kidney Care4.6yrs데이터 없음데이터 없음
Partha Das
Chief Medical Officer of DaVita International6.1yrs데이터 없음데이터 없음

5.7yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: DVA 의 관리팀은 노련하고 경험 (평균 재직 기간 5.4 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Javier Rodriguez
CEO & Executive Director5.3yrsUS$6.71m1.0%
$ 136.6m
Charles Berg
Director17.5yrsUS$322.46k0.031%
$ 4.2m
Barbara Desoer
Independent Director8.9yrsUS$384.96k0.014%
$ 1.9m
Phyllis Yale
Independent Director8.2yrsUS$374.96k0.019%
$ 2.6m
Wendy Schoppert
Independent Director1.2yrsUS$106.86k0.0018%
$ 247.7k
Pamela Arway
Independent Chair15.3yrsUS$497.46k0.029%
$ 4.0m
Dennis Pullin
Independent Directorless than a year데이터 없음0.00036%
$ 49.3k
Adam Schechter
Independent Director2yrsUS$334.96k0.0040%
$ 541.8k
Jason Hollar
Independent Director2.3yrsUS$364.96k0.0050%
$ 691.0k
Gregory Moore
Independent Director3yrsUS$355.89k0.0065%
$ 888.0k

4.1yrs

평균 재임 기간

61.5yo

평균 연령

경험이 풍부한 이사회: DVA 의 이사회는 경험(평균 재직 기간 3.9 년)으로 간주됩니다.